News search
Research 7 Oct 2024 A team of scientists from the CNIC and the CSIC has identified a key mechanism in the development of atherosclerosis in patients with the rare genetic disease Hutchinson-Gilford progeria syndrome |
Research 9 Sep 2024 The new study, published in the journal Circulation, opens a new avenue of research into treatments for the atherosclerosis associated with progeria |
Research 19 Apr 2024 The elimination of progerin from vascular smooth muscle cells, but not from endothelial cells, prevents the atherosclerosis associated with Hutchinson-Gilford progeria syndrome (HGPS) |
About the CNIC 2 Oct 2023 |
About the CNIC 3 Feb 2022 |
Research 26 Oct 2021 Scientists from the CNIC and the CIBERCV have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal |
Research 12 Mar 2019 This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease |
Research 5 Mar 2018 Investigadores del CNIC, del CIBERCV y de la Universidad de Oviedo han creado el primer modelo de ratón con aterosclerosis acelerada por la proteína progerina |
About the CNIC 20 Dec 2017 The project ‘Identifying new treatments for Hutchinson-Gilford progeria syndrome’ (HGPS) TREAT-HGPS, coordinated by Dr. Vicente Andrés will receive funding of 797,744 € over the next three years |
- 1 of 2
- next ›